Reply to Cost-Effectiveness Calculations of Human Papillomavirus Vaccination in Punjab May Be Flawed

Cancer - United States
doi 10.1002/cncr.31074
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Cost-Effectiveness Calculations of Human Papillomavirus Vaccination in Punjab May Be Flawed

Cancer
Cancer ResearchOncology
2017English

Reply to the Reply to the Letter on the Cost-Effectiveness of Human Papillomavirus in Punjab Further Distorts the Scientific Record

Cancer
Cancer ResearchOncology
2018English

Cost-Effectiveness of Two-Dose Human Papillomavirus Vaccination in Singapore

Singapore Medical Journal
Medicine
2018English

Cost-Effectiveness Analysis of Female Human Papillomavirus Vaccination in Mainland China

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Cost-Effectiveness of Quadrivalent Human Papillomavirus Vaccination in Adolescent Girls in Russian Federation

Pediatric pharmacology
2017English

Pin54 - Cost-Effectiveness of Introducing Men Vaccination Against Human Papillomavirus in the Czech Republic

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Cost-Effectiveness of 2-Dose AS04-Adjuvanted Human Papillomavirus 16/18 Vaccination Schedule in Slovakia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Reply to When Flawed Modeling Justifies Cost-Effectiveness: Making Sense of “Band-Aid” Modeling

Cancer
Cancer ResearchOncology
2018English

Human Papillomavirus Vaccination: Is It Cost-Effective in Iran?

Journal of Obstetrics, Gynecology and Cancer Research
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy